Back

Impact of a predefined pacemapping protocol for ablation of infrequent premature ventricular complexes: a prospective, multicenter study

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Oral abstract session - Atrial fibrillation and arrhythmias Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Beatriz Jauregui

UNIVERSITY HOSPITAL MIGUEL SERVET, Zaragoza (Spain)

12 More presentations in this session

Presentation thumbnail
Clinical and electrophysiological characteristics of extra-pulmonary vein triggers in patients who underwent catheter ablation for atrial fibrillation
Doctor T. Hwang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation detected at screening is not a benign condition - a comparison of clinical outcomes in screen-detected vs. hospital-detected atrial fibrillation
Mr V. Zwartkruis (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Personalized atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness. the ablate by-law single center study.
Doctor C. Teres (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation in the young: clinical characteristics, predictors of new onset and outcomes
Doctor A. Segev (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%
Doctor A. Zegard (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Oral abstract session - Atrial fibrillation and arrhythmias

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources